Epidemiology of MPN: What Do We Know?

被引：0
作者：
L. A. Anderson
M. F. McMullin
机构：
[1] Queen’s University Belfast,Centre for Public Health
[2] Queen’s University Belfast,Centre for Cancer Research and Cell Biology
来源：
Current Hematologic Malignancy Reports | 2014年 / 9卷
关键词：
Epidemiology; Myeloproliferative neoplasms; Survival; Body mass index; Diet; Benzene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The myeloproliferative neoplasms, are characterised by overproduction of myeloid cells. Chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, myelofibrosis and the very rare disorders chronic neutrophilic leukaemia, chronic eosinophilic leukaemia not otherwise specified and mastocytosis are all included in the group. Incidence and prevalence rates reported in the worldwide literature are presented in this review. Survival data on each condition is described. Information on the aetiology of the disorders is discussed including body mass index, diet, smoking and alcohol, allergies, associated medical conditions, occupation and environmental exposures with focus on recent new studies. The aetiology of the myeloproliferative neoplasms remains unknown, and this review of the current state of knowledge highlights the need for further comprehensive research.
引用
收藏
页码：340 / 349
页数：9
相关论文
共 372 条
[1]  
James C(2005)A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 1144-8
[2]  
Ugo V(2005)Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation Haematologica 90 1696-7
[3]  
Le Couédic J-P(2007)JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis N Engl J Med 356 459-68
[4]  
Mc Lornan DP(2006)MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Blood 108 3472-6
[5]  
Percy MJ(2008)MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort Blood 112 141-9
[6]  
Jones AV(2009)Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms Blood 113 6182-92
[7]  
Cross NCP(2009)Mutation in TET2 in myeloid cancers N Engl J Med 360 2289-301
[8]  
Mc Mullin MF(2013)Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 N Engl J Med 369 2391-405
[9]  
Scott LM(2014)CALR mutation studies in chronic neutrophilic leukemia Am J Hematol 89 450-3
[10]  
Tong W(2013)CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia Leukemia 27 1870-8
12345678910